Vista Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Vista Pharmaceuticals has a total shareholder equity of ₹385.8M and total debt of ₹92.6M, which brings its debt-to-equity ratio to 24%. Its total assets and total liabilities are ₹562.7M and ₹176.9M respectively.
Key information
24.0%
Debt to equity ratio
₹92.56m
Debt
Interest coverage ratio | n/a |
Cash | ₹2.42m |
Equity | ₹385.81m |
Total liabilities | ₹176.93m |
Total assets | ₹562.74m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524711's short term assets (₹240.1M) exceed its short term liabilities (₹135.8M).
Long Term Liabilities: 524711's short term assets (₹240.1M) exceed its long term liabilities (₹41.2M).
Debt to Equity History and Analysis
Debt Level: 524711's net debt to equity ratio (23.4%) is considered satisfactory.
Reducing Debt: 524711's debt to equity ratio has reduced from 37.8% to 24% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 524711 has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 524711 is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.